Short-term outcomes of lateral lumbar interbody fusion without decompression for the treatment of symptomatic degenerative spondylolisthesis at L4-5

Neurosurgical Focus
Peter G CampbellMarcus Stone

Abstract

OBJECTIVE Recently, authors have called into question the utility and complication index of the lateral lumbar interbody fusion procedure at the L4-5 level. Furthermore, the need for direct decompression has also been debated. Here, the authors report the clinical and radiographic outcomes of transpsoas lumbar interbody fusion, relying only on indirect decompression to treat patients with neurogenic claudication secondary to Grade 1 and 2 spondylolisthesis at the L4-5 level. METHODS The authors conducted a retrospective evaluation of 18 consecutive patients with Grade 1 or 2 spondylolisthesis from a prospectively maintained database. All patients underwent a transpsoas approach, followed by posterior percutaneous instrumentation without decompression. The Oswestry Disability Index (ODI) and SF-12 were administered during the clinical evaluations. Radiographic evaluation was also performed. The mean follow-up was 6.2 months. RESULTS Fifteen patients with Grade 1 and 3 patients with Grade 2 spondylolisthesis were identified and underwent fusion at a total of 20 levels. The mean operative time was 165 minutes for the combined anterior and posterior phases of the operation. The estimated blood loss was 113 ml. The most common cage ...Continue Reading

References

Jan 18, 2006·The Spine Journal : Official Journal of the North American Spine Society·Steven GlassmanLeah Carreon
Jul 11, 2006·The Spine Journal : Official Journal of the North American Spine Society·Burak M OzgurWilliam R Taylor
Jun 1, 2007·The New England Journal of Medicine·James N WeinsteinSerena S Hu
Jan 20, 2010·Journal of Spinal Disorders & Techniques·Daniel K ParkFrank M Phillips
Aug 3, 2010·Journal of Neurosurgery. Spine·Rani NasserJohn K Ratliff
Oct 13, 2010·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Christopher K KeplerRussel C Huang
Oct 23, 2010·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Ioannis D PapanastassiouFrank D Vrionis
Nov 6, 2010·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Wan-Kun HuJian Wang
Sep 29, 2011·Clinical Orthopaedics and Related Research·D'Mitri A SofianosAlpesh A Patel
Feb 5, 2013·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·R D JohnsonM Balsano
Apr 8, 2014·Journal of Neurosurgery. Spine·Marjan AlimiRoger Härtl
Mar 25, 2015·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Kaveh KhajaviAnthony Hutchison
Apr 16, 2015·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Juan S UribeUNKNOWN SOLAS Degenerative Study Group
Apr 14, 2016·The New England Journal of Medicine·Zoher GhogawalaEdward C Benzel
Oct 7, 2016·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Erlick A C PereiraKhai S Lam
Nov 16, 2016·Surgical Neurology International·Nancy E Epstein

❮ Previous
Next ❯

Citations

Apr 4, 2019·Journal of Neurosurgical Sciences·Franziska A SchmidtRoger Härtl
Sep 23, 2020·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Guang-Xun LinJin-Sung Kim
Jun 24, 2019·Current Reviews in Musculoskeletal Medicine·Raymond Hah, H Paco Kang
Jun 12, 2020·HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery·Matteo FormicaLamberto Felli
Feb 15, 2021·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Hao LiGang Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.